Targeted Treatment: The Role of Injectables in Weight Loss Management Webinar

Injectable antiobesity medications (AOMs) offer a novel approach to obesity management by targeting neurohormonal pathways to achieve sustained weight loss and improve metabolic health. Agents like liraglutide, semaglutide, and tirzepatide have demonstrated significant efficacy in clinical trials, with benefits including cardiometabolic risk reduction and treatment of sleep apnea. Incorporating AOMs into a comprehensive treatment plan that includes dietary, physical, and behavioral interventions is essential for optimizing outcomes. This educational activity will explore the mechanisms, efficacy, and safety profiles of injectable AOMs, emphasizing their integration into a comprehensive obesity treatment framework. This course will also discuss the role of interprofessional collaboration in delivering patient-centered obesity care for patients utilizing these medications.